Research ArticleINFECTIOUS DISEASES

The probacterial effect of type I interferon signaling requires its own negative regulator USP18

See allHide authors and affiliations

Science Immunology  28 Sep 2018:
Vol. 3, Issue 27, eaau2125
DOI: 10.1126/sciimmunol.aau2125

Article Information

vol. 3 no. 27

PubMed: 
Published By: 
History: 
  • Received May 17, 2018
  • Accepted August 29, 2018

Author Information

  1. Namir Shaabani1,2,*,,
  2. Nadine Honke2,3,*,
  3. Nhan Nguyen1,
  4. Zhe Huang1,
  5. Kei-ichiro Arimoto4,
  6. Daniel Lazar1,
  7. Taylor K. Loe5,
  8. Karl S. Lang2,
  9. Marco Prinz6,7,
  10. Klaus-Peter Knobeloch8,
  11. Dong-Er Zhang4,9,10 and
  12. John R. Teijaro1,
  1. 1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
  2. 2Institute of Immunology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
  3. 3Department of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany.
  4. 4Moores UCSD Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
  5. 5Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
  6. 6Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
  7. 7BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany.
  8. 8Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
  9. 9Department of Pathology, University of California San Diego, La Jolla, CA 92093, USA.
  10. 10Division of Biological Science, University of California San Diego, La Jolla, CA 92093, USA.
  1. Corresponding author. Email: shaabani{at}scripps.edu (N.S.); teijaro{at}scripps.edu (J.R.T.)
  1. * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: September 2018 to November 2018

AbstractFullPdf
Sep 201803209329
Oct 20184604961731
Nov 20181385114